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Tuberculosis (TB) is currently the number one killer among infectious diseases worldwide. Lipids 
are abundant molecules during the infectious cycle of Mycobacterium tuberculosis (Mtb) and studies 
better mimicking its actual metabolic state during pathogenesis are needed. Though most studies 
have focused on the mycobacterial lipid metabolism under standard culture conditions, little is known 
about the transcriptome of Mtb in a lipid environment. Here we determined the transcriptome of Mtb 
H37Rv in a lipid-rich environment (cholesterol and fatty acid) under aerobic and hypoxic conditions, 
using RNAseq. Lipids significantly induced the expression of 368 genes. A main core lipid response was 
observed involving efflux systems, iron caption and sulfur reduction. In co-expression with ncRNAs and 
other genes discussed below, may act coordinately to prepare the machinery conferring drug tolerance 
and increasing a persistent population. Our findings could be useful to tag relevant pathways for the 
development of new drugs, vaccines and new strategies to control TB.
Mycobacterium tuberculosis (Mtb) remains a leading infectious agent since first described by Robert Koch as the 
cause of tuberculosis (TB) and is now the first killer among infectious diseases1. Mtb successfully disseminates 
based in part on its exceptional mechanisms of infection, survival, persistence and dormancy. Drug tolerance and 
drug resistance, metabolic reactivation from dormancy, and dissemination inside the host, all contribute to its 
successful pathogenesis and transmission. The World Health Organization declared TB as a global emergency in 
1993 and TB research has greatly increased ever since1. However, we often study the virulence and survival factors 
of Mtb from liquid cultures under “in vitro standard conditions”, which usually implies dextrose as carbon source 
and an in vitro or in vivo TB model. Anyhow, studies have shown that it is important to control previous condi-
tions of mycobacterial growth before setting up a TB model. For instance, implementation of a detergent-free 
medium to culture Mtb before setting a macrophage infection model, rather than using a medium containing 
Tween 80, significantly changed the transcriptome and pathways taken by murine macrophages2. Likewise, imple-
mentation of lipids in in vitro dormant models has yielded better mycobacterial recovery and different transcrip-
tomic profiles during in vitro resuscitation, compared to dextrose as sole carbon source3,4. Lipids are important 
molecules during the life cycle of Mtb as well as during the metabolic dynamics within the host5,6. Mtb promotes 
and modulates its phagocytosis using complex lipids of the cell wall7 and enters the macrophage through lipid 
rafts, which mainly contain host cholesterol8. Also, Mtb recruits the protein TACO allocated in cholesterol-rich 
zones to avoid the phagosome-lysosome formation9. The granuloma formation is also promoted by released lipid 
microvesicles of Mtb, besides other virulence factors10,11, which led some authors to suggest the granuloma might 
be protecting the mycobacteria rather than the host12. Nevertheless, Mtb is not restricted to its own lipid home-
ostasis, it also influences host lipids by promoting the recruitment of low density lipoproteins and the formation 
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of foamy macrophages13 producing cellular necrosis and caseous granuloma14 rich in cholesterol, triglycerides 
and lactosylceramides10. It is proposed that Mtb uses mainly lipids as carbon and energy source, rather than 
dextrose, during latency3,15,16. By using 14C-labeled lipids, transmission electron microscopy and auramine-nile 
staining, several studies have demonstrated that fatty acids and cholesterol consumption by Mtb lead to cytoplas-
mic lipid bodies accumulation, cell wall remodelling or synthesis of released lipoproteins11,16–19. Moreover, during 
active TB, Mtb evades the host immune cells by exchanging lipids in its cell wall and hiding its earlier identified 
pathogen-associated molecular patterns (PAMPs)20. Also, sputum from TB patients reflects the lipid environment 
from which mycobacteria is coming from, made up mainly of cholesterol, palmitic, stearic and oleic acids21,22. 
Sputum becomes in turn the microenvironment where the transmissible stage of Mtb resides, whose microscopic 
phenotype and transcriptional profile suggested there is a shift in the lipid metabolism. Mtb recovered from 
sputum showed cytoplasmic lipid bodies revealed with auramine-nile red staining, significant overexpression of 
the large Kst-R regulon of cholesterol catabolism, overpression of tgs1 gene required for triacylglycerol synthesis 
and down-regulation of genes involved in phthiocerol dimycocerosate and phenol glycolipid synthesis indicating 
cell wall remodeling23,24. There is also evidence that hypercholesterolemia increases susceptibility to TB in mice25 
and a survey in Singapore found positive correlation between a cholesterol diet and an increased risk to active 
TB in Chinese population26. It is thus important to investigate not only the mycobacterial lipid metabolism but 
also, the mycobacterial response to lipids and the host lipid homeostasis during TB infection. Studies that better 
mimic the actual metabolic state of Mtb during pathogenesis are needed to fully tag therapeutic targets against 
TB. Although previous studies have focused on the mycobacterial lipid metabolism under different “standard” 
conditions (drugs, stress), less is known about the transcriptome of Mtb in a model that better mimics the lipid 
environment of the caseous granuloma, rich in cholesterol and fatty acids. This could uncover an unexplored 
field, potentially useful for the development of new drugs, vaccines and new strategies for controlling TB. In this 
study we determined the transcriptome of Mtb in a lipid-rich dormancy model through RNAseq technology, 
which has the advantage over qRT-PCR or microarrays, of producing the transcriptome of the organism with 
a higher resolution, including codifying and non-codifying genes, intergenic regions, small RNAs or antisense 
transcripts. Moreover, the overexpression of some genes is perfectly quantified without noise, which is usually 
found in other fluorescence-based systems. This study exposes the transcriptome landscape of Mtb H37Rv in the 
presence of the most abundant lipids inside the host, specifically, cholesterol and long chain fatty acids (C16:0, 
C18:0, C18:1), using dextrose carbon source as control, under aerobic and hypoxic conditions27.
Results
In vitro cultures of Mtb were grown in the presence of lipids (cholesterol and fatty acids) as previously described3 
and parallel cultures with dextrose were used as control. Six conditions were studied: lipid exponential phase 
(LE), lipid stationary phase (LS), lipid NRP1 stage (LNRP1), dextrose exponential phase (DE), dextrose station-
ary phase (DS) and dextrose NRP1 (DNRP1). Mycobacterial RNA from all conditions was subjected to RNAseq 
analysis. Codifying genes (CDS) and non-coding RNAs (ncRNA) were classified according to functional catego-
ries listed in Tuberculist28, IGRs and sRNA candidates16,29, not listed in Tuberculist28, were added and featured as 
genes in the annotation file. After quality control evaluation and trimming of bad.
Qualitative reads, a mean of 54.8 ± 9.4 million paired reads per individual library were detected. 76.3 ± 3.9% 
of total reads mapped in the sense direction, while 4.3 ± 2.5% mapped in the anti-sense direction. It is worthy 
of notice that DS samples had slightly more anti-sense reads (9 ± 0.6%) than the rest of the conditions (Fig. 1A). 
Deep sequencing analysis of the sense reads showed that more ncRNAs were found in DS, LS and LNRP1, 
32 ± 1.4%, 41 ± 0.8% and 28 ± 3.3% of total aligned sense-reads, respectively (Fig. 1B). Finally, the principal com-
ponent analysis (PCA) and the clustering heatmap plots showed that the samples clustered by their biological 
replicates (Fig. 2).
Figure 1. RNA-seq mapping results for every experimental condition and biological replicates. Sense and anti-
sense mapping is figured in the chart (A). Grey bars show the reads mapped in the sense direction. Not mapped 
reads were mapped in the anti-sense direction and are represented by black bars. The chart (B) show stacked 
columns of total mapped reads in the sense direction. Gray bars with white dots show the percentage of reads 
aligned to ncRNA and light gray bars show the percentage of reads aligned to CDS. Detailed data of RNA-seq 
mapping can be seen in the Supplemental Material, Table S3.
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Differential gene expression analysis for lipid conditions. To investigate the impact of lipids during 
the different stages, differential gene expression (DGE) analysis for the first general lineal model was performed 
comparing lipid conditions vs dextrose (D vs L). Six replicates for each dextrose and lipid group were performed, 
ordered in three subgroups (exponential, stationary and NRP1). Differentially expressed genes were filtered using 
a false discovery rate (FDR) of <0.05 and a log2 fold change >1 or <−1 for biological significance. After filtering, 
368 genes were found differentially expressed in the presence of lipids (Fig. 3 and Table S1 in the Supplemental 
Material) representing 7.8% of the total covered genes. From these, 183 genes decreased and 185 increased their 
expression (Fig. 3A). As shown in the PCA plot and in the heatmap visualization (Fig. 3B), the 368 genes clustered 
by the carbon source (lipid or dextrose) and by biological replicates. Regarding the functional categories, most 
of the differentially expressed genes belonged to the categories of conserved hypothetical proteins, cell wall and 
cell processes, intermediary metabolism and respiration and the appended category of IGR and sRNA candidates 
(Fig. 3C). These results were not unexpected given the substantial number of genes that are included in these four 
categories compared with the others in the whole genome of Mtb. For this reason, we proceeded to perform a dif-
ferential functional category analysis, which took into account the category size. Results showed that the category 
of insertion sequences and phages as well as the PE/PPE category decreased their expression and, as expected, 
the presence of lipids prompted the expression of the lipid metabolism category, together with the intermediary 
metabolism and respiration category (Fig. 3D and Supplemental Material Table S4). Specifically, the ten genes 
with increased expression from the lipid metabolism were ltp2, pks2, tgs2, mutA, rv3087, rv1425, fadA5, fadD2, 
fadE7 and fadE9. Whilst the genes with diminished expression from the insertion sequences and phages category 
were rv2646, rv3427c, rv2647, rv1199c and rv2512c and from the PE/PPE family were PE_PGRS62, PE15, PE21, 
PE22, PE23, PE25, PE3, PE8, PPE1, PPE21, PPE22, PPE23, PPE24, PPE34, PPE57 and PPE67. It also draws our 
attention the MTS2823 ncRNA from the category of stable RNA, since it was the only one from this category with 
significant and differential increased expression in the presence of lipids, in the first general linear model (D vs L).
Additionally, a differential pathway analysis (DPA) was performed using the KEGG database30, to determine 
the impact of lipids over all mycobacterial phases. Again, dextrose was used as control, growth phases were set 
as a batch effect. This analysis predicted significantly induced or repressed pathways, either in a direct or indirect 
mode. The results of this analysis confirmed the induction of the steroid degradation and fatty acid degradation 
pathways (see Supplementary Material Table S5). Additionally, lipids promoted two-component systems, pyru-
vate metabolism, carbon metabolism, lysine degradation, valine, leucine and isoleucine degradation, tryptophan 
metabolism, butanoate metabolism and oxidative phosphorylation.
Differential gene expression analysis for every stage of growth of Mtb. Three linear models of 
DGE were made for the lipid growth stages LE, LS and LNRP1, with dextrose cultures (DE, DS and DNRP1) as 
controls. This analysis identified 1241 (557 down- and 684 up-regulated) differentially expressed genes in LE; 2043 
(1196 down- and 847 up-regulated) differentially expressed genes in LS, while the LNRP1 stage showed the small-
est number of genes, with 138 (43 down- and 95 up-regulated) differentially expressed (Fig. 4 and Supplementary 
Material Table S2). The number of genes differentially expressed per category can be seen in Fig. 5A. Again, 
the biggest categories: conserved hypothetical proteins, cell wall and cell processes, intermediary metabolism 
and respiration and the appended IGRs and sRNA candidates, had the higher number of significantly expressed 
genes. The differential functional categories analysis took into account the size of every category (Fig. 5B and 
Supplemental Material Tables S6, S7 and S8). Through this analysis, it was possible to define the categories up- 
and down-regulated in every phase of growth. The PE/PPE category was significantly down-regulated in the two 
models of dormancy in the presence of lipids (LS and LNRP1), while the lipid and the intermediary metabolism 
and respiration were significantly up-regulated in both stages. Among the differences between these two stages, 
Figure 2. Plots of the principal component analysis (A) and the clustering-heatmap (B) of all genes after 
normalization using edge R. For the PCA plot, the data was rlog transformed. For the clustering heatmap, 
normalized counts were rescaled between −3 and 3, clustering was based on Pearson correlation. The six 
experimental conditions clustered with their biological replicates.
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we had two categories up-regulated in LS, information pathways and cell wall and cell processes categories, while 
the virulence and regulatory proteins categories were up-regulated during the lipid hypoxia LNRP1. On the other 
hand, the exponential stage only had the information pathways category significantly down-regulated.
The main core lipid response. Figure 6 shows the number of genes that belong to the core induced by the 
presence of lipids. It shows a Venn diagram with the set of significantly increased genes in lipids, from the first 
DGE analysis (D vs L), that overlaped with significantly increased genes in the subsequent DGE lineal models per 
stage of growth ([DE vs LE], [DS vs LS] and [DNRP1 vs LNRP1]). Although all of them were significantly over-
prexpressed in the presence of lipids, only six genes from the comparison D vs L overlapped in the three stages of 
Mtb, and they were called “the main core lipid response”, comprising Rv3161c, Rv3160c, Rv0678, Rv1217c, PPE53 
and che1. Genes from the remain sets and detailed gene expression data can be checked in the Supplementary 
Material, Table S1 and S2.
qRT-PCR validation. Validation of RNAseq results was made through qRT-PCR, for which a set of ten 
significantly up-regulated genes in the presence of lipids were confirmed. Four technical replicates for each two 
biological replicates were tested for gene expression at every stage of growth in lipids or dextrose. Seven of the 
most significantly upregulated genes from the first linear DGE analysis (comparing L vs D) were chosen: rv3160c, 
rv3161c, PPE53, che1, mmpS5, hsd4A and usfY. Additionally, three significantly upregulated genes from the DGE 
analysis for every stage of growth were chosen based on lipid phase exclusivity: hrp1 was overexpressed in LE, 
rv1639c in LS and rv0560 in LNRP1. Absolute gene expression of the ten genes was determined and normalized to 
16 S rRNA gene (Fig. 7A). For relative quantification, the absolute transcription level of genes in every lipid stage 
was compared with their respective dextrose control (LE/DE, LS/DS and LNRP1/DNRP1; Fig. 7B).
Similar to the DGE results, the seven chosen genes from the comparison L vs D were up-regulated in the three 
lipid conditions (LE, LS and LNRP1) by qRT-PCR, though the upregulation of PPE53 in LS and che1 in LE were 
not statistically significant. Likewise, hrp1, rv1639c and rv0560 were the most expressed in LE, LS and LNRP1, 
respectively, although hrp1 was not exclusive of LE due to the given significant overexpression in LS as well (Fig. 7 
and Supplemental Material S9 for statistics).
Figure 3. Differential gene expression of Mtb H37Rv in presence of lipids. Conditions with dextrose were used 
as control and growth stages were used as batch effect. Counts were normalized using edge R, all genes with a 
CPM greater than 1 in at least 2 samples were used in the analysis. 368 significant differentially expressed genes 
were found. (A) Volcano plot (on the left) and its Venn diagram (on the right) where 185 genes with diminished 
expression and 183 genes with increased expression in presence of lipids are specified. (B) PCA and heatmap 
plots of the 368 differential expressed genes that were rescaled between −3 and 3, clustering was based on the 
Pearson correlation. (C) Number of differentially expressed genes by functional categories are shown, circle 
sizes are proportional to the number of genes with significant differential expression, total number of genes 
per functional category listed in tuberculist are indicated in parenthesis. (D) Differential functional categories 
analysis. Only significant expressed categories (FDR < 0.05) are indicated.
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Discussion
Previous studies have shown a close link between persistent mycobacteria and drug tolerance31. Persistent 
mycobacteria are presumed to be the reason for many treatment failures, even in the presence of drug suscep-
tible mycobacteria. The problem can reside in multiple mycobacterial phenotypes, including the persistent 
non-culturable mycobacteria, which cannot be subjected to DST. All these populations have in common the pres-
ence of host lipids, at several levels, from host membranes to caseous granuloma or sputum. In fact, Mtb not only 
modulates its own lipid metabolism but also influences the host lipid metabolism to be fully surrounded by lipids 
at one point of its life cycle5. Through RNAseq we confirmed that lipid accession is one more stimulus, besides 
other stress factors, by which Mtb increases their persistent population. The differences between the Rodriguez et 
al., study16 and ours are mainly based on the culture conditions and the bioinformatic analysis. Rodriguez et al. 
selected the even-length long-chain fatty acids (LC-FAs) as the sole carbon source. In the present study, to gain 
more insight into the M. tuberculosis adaptation to a fatty acid environment, we implemented cholesterol together 
with the fatty acids as carbon source, considering the propionyl-CoA pool, which is a central metabolite to pro-
duce methyl-branched lipids of the cell wall. Another difference is the hypoxic condition evaluated in the pres-
ence of lipids and dextrose of this study. Limited oxygen is a feature of granulomas and hypoxic models have been 
frequently used to study dormant mycobacteria. Additionally, the library construction, normalization of the data, 
DGE analysis and statistical analysis were completely different between both studies. Yet, the study of Rodríguez 
et al., must be considered since the authors confirmed that fatty acids prompted a phenotype of dormancy and the 
study highlighted relevant features of the transcriptome of Mtb during fatty acid consumption.
Here, Mtb differentially expressed a core of 368 genes in the presence of lipids (183 down- and 185 
up-regulated). Our study included lipids in aerobic exponential growth, aerobic stationary phase and hypoxic 
stage (NRP1), the last two better mimicking dormancy27,32. Since lipids are present and involved in most stages of 
Mtb during TB pathogenesis6, these 368 genes may be clues in the mycobacterial metabolism during its survival. 
The genes Rv3161c, Rv3160c, Rv0678, Rv1217c, PPE53 and che1, form what we call “the main core lipid response”; 
and have been linked to processes of drug detoxification, iron acquisition and efflux and transport systems also 
co-expressed with the mmpL5-mmpS5 operon. The correlated overexpression of Rv3160c-RV3161c and PPE53 
have also been found in the presence of cell wall and respiration inhibitors (Fig. 8)33,34. Thus, it is proposed 
that this operon is required for detoxification of drugs35, although there is no evidence of its direct involvement 
in drug resistance36. This operon is co-expressed with mmpS5-mmpL5 in the presence of drugs (Fig. 9)33 as it 
happened in the presence of lipids of our study. The MmpS5-mmpL5 efflux pump is not only related to drug 
Figure 4. Differential gene expression of Mtb H37Rv in every stage of growth in presence of lipids. Dextrose 
conditions were used as controls. The heatmap and volcano plots are shown in figure (A) for the 1241 
differentially expressed genes in LE, figure (B) shows the 2043 differentially expressed genes in LS and figure 
(C) shows the 138 differentially expressed genes in LNRP1. Normalized counts in the heatmap were rescaled 
between −3 and 3 with clustering based on Pearson correlation and differentially expressed genes were 
considered significant using a false discovery rate of <0.05 and a log2 fold change >1 or <−1.
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Figure 5. Differential gene expression per functional categories of every stage of growth of Mtb. (A) The 
number of differentially expressed genes are shown by functional categories, where circle sizes are proportional 
to the number of genes with significant differential expression. Blue circles are used for genes with diminished 
expression and red circles are used for genes with increased expression. Total number of genes per functional 
category listed in tuberculist are indicated in parenthesis. (B) Differential functional Categories analysis are 
indicated in tables for every stage of growth, wherein the mean log2 fold change is significantly different from 
the general mean log2 fold change at a FDR <0.05.
Figure 6. Core of genes induced by the presence of lipids.
www.nature.com/scientificreports/
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resistance but siderophore transportation37,38. Another gene from the mean core lipid response related to iron 
utilization was che1, whose codified product is a ferrochelatase. This gene resides in a sulfur reduction operon, 
constituted by sirA, cysH, che1, ggtB39,40. The role of Che1 is to insert iron into a siroheme.
Rv1217c (from the mean core lipid response) is predicted to be part of the operon integrated by Rv1216c, 
Rv1217c, Rv1218c and Rv1219c39. All were differentially overexpressed in the presence of lipids in our study 
(Table S1). Likewise, this operon is co-expressed with mmpS5-mmpL5 in the presence of the drugs41 as it hap-
pened in the presence of lipids of our study.
It is also important to mention the overexpression of an efflux pump codified by mmr gene and a sulfur reduc-
tion operon (Rv2391 – Rv2394). All these genes are linked somehow and were significantly overexpressed in the 
presence of lipids in this study (Table S1). Mmr is an efflux pump involved in transport of multidrugs and codified 
next to Rv3066 that encodes a transcriptional regulator belonging to the deoR-family. They belong to the same 
operon39 and Rv3066 is predicted to repress mmr42. Rv3066 was not up-regulated under lipid conditions; in fact, 
its transcription was significantly diminished in LS stage allowing transcription of mmr. Hence, we hypothesize 
that all genes mentioned above are coordinated to act not only at the level of intracellular redox balance but also 
preparing the machinery that confers drug tolerance to Mtb.
According to the differential functional category analysis (DFCA), it is not surprising that lipids mostly 
induced the expression of the lipid metabolism category (Fig. 3D). This was also confirmed by a differential path-
way analysis using KEGG30, which showed activation of fatty acid degradation and steroid degradation pathways. 
Specifically, essential genes for in vitro growth in cholesterol43 such as cyp125, kstD, hsaB, hsaC, fadA5, ltp2 and 
pks2 were induced, as well as genes for lipid degradation, including fadE9, fadD2, fadE7. Additionally, there were 
genes involved in lipid biosynthesis, such as for triacylglycerol (TAG) (tgs2, Rv3087 and Rv1425) and mutA, nec-
essary for multimethyl-branched lipid biosynthesis through the methylmalonyl pathway. Based on this, we can 
assume that Mtb used cholesterol and fatty acids as carbon source and synthetized new macro-lipids, either for 
lipid deposition as TAG or for cell wall remodeling.
There were eight PE/PPE genes overexpressed in the DGE core (PPE53, PE_PGRS54, PE_PGRS5, PE_PGRS10, 
PE_PGRS57, PE_PGRS15, PE_PGRS53, PE_PGRS33). From these, only PPE53 was strongly up-regulated in the 
three lipid phases of this study. The role of PE/PPE proteins remains uncertain but evidence suggests that they 
confer virulence variability to mycobacteria. A system of oxidative stress was significantly overexpressed in the 
lipid stationary phase (LS) compared to cultures in dextrose (DS). This system includes the enzymes KatG, SodA 
and AhpC44, all essential for virulence44. Also, during stationary phase, lipids induced expression of vapC1, 
vapC22, vapB1, vapB10, vapB48 and vapB46, while during exponential phase (LE) and hypoxia (LNRP1), there 
was overexpression of complete modules vapB22/vapC22 and vapB9/vapC9, respectively (Table S2), suggesting 
that lipids promote a higher survival through vapBC components in exponential and hypoxic phases and may 
contribute to persistence population appearance.
Figure 7. Validation of ten differential expressed genes in lipid conditions by qRT-PCR. (A) Absolute gene 
expression during DE (gray bars), LE (black bars), DS (light blue bars), LS (dark blue bars), DNRP1 (light green 
bars) and LNRP1 (dark green bars) conditions. Data were normalized to the number of copies of rrs gene and 
results are expressed as log10 of the mean ± SD number of copies per microgram of RNA. Asterisks indicate 
significant diference between a given lipid stage compared to its respective dextrose stage (LE vs DE, LS vs 
DS and LNRP1 vs DNRP1), with P < 0.05 considered statistically significant. (B) The relative quantification is 
expressed as the ratio of [transcription in LE/transcripion in DE] (black bars), the ratio of [transcription in LS/
transcription in DS] (blue bars) and the ratio of [transcription in LNRP1/transcription in DNRP1] (green bars).
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Lipids also induced the overexpression of non-codifying genes in this study. At least one third of the Mtb tran-
scriptome, including rRNA, belongs to non-codifying RNAs (ncRNAs)45. Our results confirmed that the tran-
scriptome of Mtb drifts towards a greater proportion of non-codifying transcripts, out of rRNA, under different 
in vitro stress conditions as previously reported16,45,46. In this study, those ncRNA transcripts were more abundant 
Figure 8. Correlated gene expression among PPE53, Rv3160c and Rv3161c. Plots show data reported by 
Boshoff and colleagues through microarray assay, which is deposited in the correlation catalog of the TBDB data 
base41,42. (A). Comparison between PPE53 and Rv3160c; (B). Comparison between PPE53 and Rv3161C; (C). 
Comparison between Rv3161c and Rv3161c. Black frames and circles highlight positive correlation between 
two genes in samples of Mycobacterium tuberculosis under diferent conditions. Gene expression responses of 
Mtb to 76 treatment groups are represseented by red dots. Plots resumed experimental categories: 1) samples 
of Mtb under inhibitors of cell wall synthesis (left), 2) samples of Mtb under diferent inhibitors of respiration 
(middle) and 3) “others” (on the right) inlcludes 8 categories more, such as acidified médium, agents that affect 
DNA integrty or topology, aromatic amides that can be hydrolyzed intracellylary, growth associated with dosR 
regulon, inhibitors of protein synthesis, minimal medium with palmitate or succinate as carbon, starvation 
and transcriptional inhibitors. It can be seen that PPE53, Rv3160c and Rv3161c are mainly co-expressed in 
compounds that affect cell wall synthesis and respiration. On the other hand, these genes are not induced by 
compounds from the cathegory “others”.
www.nature.com/scientificreports/
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in the stationary phases and under lipid hypoxia (Fig. 1B; DS, LS and LNRP1), confirming previous studies that 
suggest that ncRNA are strongly involved in mycobacterial survival. The small ncRNA MTS2823 was the only 
significantly overexpressed ncRNA found from the stable RNA’s category (Fig. 3C). The DGE analysis showed 
that up-regulation of MTS2823 was co-expressed with sigE which was up-regulated in the lipid exponential phase 
with significant down regulation of prpC/prpD genes, needed for the methylcitrate cycle (Table S2). There was 
also overexpression of desA3 in the lipid hypoxic condition (LNRP1).
In summary, using RNAseq we determined the transcriptomic profile induced by a mixture of cholesterol, pal-
mitic, stearic and oleic acids, in Mtb H37Rv, over three metabolic stages, exponential and stationary stages, as well 
as for the non-replicating persistence stage 1 of hypoxia (NRP1). The transcriptomic profile suggested that cho-
lesterol and fatty acids were used as carbon source and induced what we have called the mean core lipid response. 
This mainly induced a machinery that confers drug tolerance to a vast variety of drugs but also ensures the main-
tenance of iron caption and sulfide production, necessary for enzymes and coenzymes needed for redox balance 
Figure 9. Correlated gene expression between Rv3161c and mmpL5. Plots show data reported by Boshoff 
and colleagues33 through microarray assay, which is deposited in the correlation catalog of the TBDB data 
base41,53. Black frames highlight positive correlation between Rv3161c and mmpL5 (>1 for both) in samples 
of Mycobacterium tuberculosis under diferent conditions. Gene expression responses of Mtb to 76 treatment 
groups are represseented by red dots. Plots resumed experimental categories: 1) samples of Mtb under inhibitors 
of cell wall synthesis (upper left), 2) samples of Mtb under diferent inhibitors of respiration (upper right), 3) 
in presence of aromatic amides (lower left) and 4) “others” (lower right) inlcludes 7 categories more, such as 
acidified médium, agents that affect DNA integrty or topology, growth associated with dosR regulon, inhibitors 
of protein synthesis, minimal medium with palmitate or succinate as carbon, starvation and transcriptional 
inhibitors. DCCD: Dicyclohexylcarbodiimide, TRZ: Thioridazine, CPZ: Chlorpromazine, CFZ: Clofazimine, 
KCN: Potassium cyanide, PZA: Pyrazinamide33,54. It can be seen that Rv3161c and mmpL5 are mainly co-
expressed in compounds that affect cell wall synthesis and respiration as well as in presence of aromatic amides. 
Besides, these genes are not co-expressed by compounds from the cathegory “others”.
www.nature.com/scientificreports/
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and production of central metabolites, such as acetyl-CoA and methyl-malonyl-CoA, needed for de novo lipid 
biosynthesis (Fig. 10). As additional studies confirm the importance of lipids during the TB pathology, the core 
lipid response may give us some clues to target relevant pathways in the Mtb metabolism and find better thera-
peutic targets, for antibiotic and vaccine development as well as for better therapeutic regimens of TB patients.
Methods
Bacterial strain and growth conditions. Mtb cultures were handled under the specific biosafety recom-
mendations established by WHO47. Mtb H37Rv was cultured in Dubos broth (Difco), without glycerol, containing 
0.5% albumin (Sigma Fraction V), supplemented with either 0.2% dextrose or a lipid mixture (oleic acid, palmitic 
acid, stearic acid, at final concentration of 0.001% each, plus 0.01% cholesterol). Three growth phases of Mtb were 
cultivated for each carbon source (dextrose or lipids), as it was previously described by Soto-Ramirez et al., 2017. 
Specifically, Mtb was grown until reaching 1) its aerobic exponential phase (DE: dextrose exponential phase and 
LE: lipid exponential phase), 2) its aerobic stationary phase (DS: dextrose stationary phase and LS: lipid stationary 
phase) and 3) its NRP1 stage of dormancy (DNRP1: dextrose NRP1 stage and LNRP1: lipid NRP1 stage), for which, 
a parallel culture supplemented with methylene-blue (1.5 mg mL) was used as an indicator of oxygen depletion. A 
total of six experimental conditions were assessed and at least two biological replicates were done for all conditions. 
For lipid stages Mtb was grown to exponential stage containing 2.4 × 106 ± 9 × 105 CFU/mL, OD600 between 0.3 
to 0.5, at day 7 of incubation, stationary stage containing 2.9 × 106 ± 2 × 106 CFU/mL, OD600 between 0.7 to 0.9, 
at day 15 of incubation and NRP1 stage containing 2.7 × 106 ± 8 × 105 CFU/mL, OD600 between 0.3 to 0.4, at day 
8 of hypoxia. For dextrose stages Mtb was grown to exponential stage containing 8.3 × 106 ± 1.86 × 106 CFU/mL, 
OD600 = 0.3, at day 7 of incubation, stationary stage containing 2.9 × 108 ± 9.43 × 106 CFU/mL, OD600 = 0.6, at day 
15 of incubation and NRP1 stage containing 5.3 × 106 ± 1.1 × 106 CFU/mL, OD600 = 0.3, at day 5 of hypoxia.
RNA isolation. Total RNA was isolated from all Mtb cultures as previously described48. All work involving 
viable Mtb was performed in a dedicated Biosafety Level 3 (BSL 3) laboratory. In short, each culture (200 mL) 
was harvested by centrifugation and pellets were resuspended in 2 mL of lysis buffer (6 M guanidinium chlo-
ride, 0.1% Tween 80, 1 mM 2-mercaptoethanol, 10 mM EDTA). Cells were lysed mechanically in a FastPrep cell 
disrupting equipment (Thermo Scientific) with 150 μm–to 200 μm glass beads (Sigma-Aldrich) by performing 
three lysis cycles of 45 s, at 4.0 m/s followed by two lysis cycles of 15 s at 6.5 m/s. Nucleic acids were extracted with 
phenol-chloroform-isoamyl alcohol (25:24:1) and RNA was precipitated with 0.4 volume of absolute ethanol. Total 
RNA was purified three times with Trizol reagent (Invitrogen), RNA integrity was analyzed with a Bioanalyzer 
(Agilent Technologies), quantified by spectrophotometry with the NanoDrop ND-1000 (Thermo Scientific) 
and DNA absence was evaluated by qPCR, using primers for amplification of the gene rpsL (see Supplementary 
Material, Table S10). Finally, RNA was dissolved in DEPC-treated water and stored at −70 °C until further use.
Figure 10. Principal metabolic pathways activated by the core lipid response.
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RNA amplification and sequencing library preparation. Concentration and quality of the total 
extracted RNA was checked by using the ‘Quant-it ribogreen RNA assay’ (Life Technologies, Grand island, NY, 
US) and the RNA 6000 pico chip (Agilent Technologies, Santa Clara, CA, USA), respectively. One µg of RNA 
was used to start the library preparation. Ribosomal RNA was removed from the total RNA using the ‘Ribo-zero 
Magnetic Bacteria kit’ (Epicentre), according to manufacturer’s protocol. Subsequently, RNA cleanup was per-
formed with the ‘Rneasy MinElute Cleanup kit’ (Qiagen). After fragmentation and random priming, first and 
second strand cDNA was synthesized using the ‘NEBNextUltra Directional RNA Library Prep Kit for Illumina’ 
(New England Biolabs), according to manufacturer’s protocol. After adapter ligation, the library was cleaned up 
twice using the Agencourt AMPure XP system (Beckman Coulter Inc.), followed by a 14 cycles PCR amplifica-
tion, according to manufacturer’s instructions. Then, the library underwent a final cleanup using the Agencourt 
AMPure XP system (Beckman Coulter Inc.) after which the libraries’ size distribution and quality was assessed 
using a high sensitivity DNA chip (Agilent Technologies). Libraries were subsequently quantified by qPCR, 
according to Illumina’s protocol ‘Sequencing Library qPCR Quantification protocol guide’, version February 2011. 
Finally, equimolar quantities (1.9 pM) of all libraries were sequenced by a high throughput run on the Illumina 
NextSeq. 500 sequencer using 2 × 150 bp paired-end reads and a 1% Phix spike-in control.
Read alignment and differential gene-expression analysis. A custom.gff annotation file was made 
for reference genome NC_000962.3 of Mtb H37Rv. The original RefSeq annotation file was appended with all 
sRNA candidate and IGR’s described in the Supplementary data Miotto et al., 2012 and Rodriguez et al., 2014. 
Annotations on the same strand with more than 50% overlap with another annotation were considered dupli-
cates. After filtering by origin, where RefSeq annotations were retained over Rodriguez et al., which in turn were 
retained over Miotto et al., a single duplicate with maximal length remained. All annotated features: genes, IGRs 
and candidates were annotated as genes for gene expression analysis.
To quantify gene expression, the RNA-seq Analysis tool from the CLC Genomics Workbench 9.0.1 software 
(CLC Bio, Aarhus, Denmark) was used to map the reads to gene regions only with strand-specificity set to reverse 
and default settings. Count tables were made by counting the reads that mapped against the genes and exported 
from CLC.
To explore if the samples from different treatment groups clustered together and to detect outlier samples, a 
Principal Component Analysis (PCA) was performed in R on the rlog49 normalized and transformed counts of 
the genes expressed at cpm above 1 in at least 2 samples.
Differential gene expression analysis was performed using edgeR50. Genes were only retained if they were 
expressed at a cpm above 1 in at least 2 samples. Four different models were built. The first general linear model 
was made with 2 treatments “dextrose” vs “lipid”, defining the effects from the growth phases “exponential”, “sta-
tionary” and “NRP1” as batch effect. The last three general linear models were made with 2 treatments each 
“dextrose exponential” vs “lipid exponential”, “dextrose stationary” vs “lipid stationary” and “dextrose NRP1” vs 
“lipid NRP1”. A differential functional categories analysis was done for the mentioned four comparisons, using 
dextrose groups as control, lipids as treatment and growth stages as batch effect. Likewise, a differential pathways 
analysis was performed using KEGG30 for the general linear model D vs L.
The set of genes with significant increased expression obtained from the first general linear model (DGE: D vs 
L), that overlapped with significant increased expression in the subsequent DGE lineal models per stage of growth 
([DE vs LE], [DS vs LS] and [DNRP1 vs LNRP1]) were grouped in a Venn diagram. This set of genes was defined 
as the “core lipid response”. Additionally, only those genes that overlapped in the three stages of Mtb, were called 
“the mean core lipid response”.
The data is available at the GEO database of NCBI. The accession number is GSE100097.
qRT-PCR. The total transcripts of selected genes were measured by real-time qRT-PCR. cDNA was synthe-
tized from 1 µg of total RNA using the “SuperScriptTM First-Strand Synthesis System for RT-PCR” kit (Invitrogen). 
Quantification was performed with gene-specific primers (see Supplemental Material Table S10), which were 
designed by the Primer-Blast tool51 and based on the genome sequence for Mtb H37Rv with Gene bank access 
number NC_000962.3. qPCR was performed by using the start SYBR Green I Master mix and the LightCycler® 
480 system (Life Science Roche). Quantification was carried out in the six experimental conditions (DE, LE, DS, 
LS, DNRP1, LNRP1), using four technical replicates for each two biological replicates. The qPCR was subjected 
to 40 cycles of amplification and a melting curve analysis was performed for ensuring that the fluorescence lev-
els detected were due to the amplification of a specific product. To determine the absolute gene expression, a 
standard curve was obtained for each set of primers by using 10-fold dilutions of known amounts of Mtb H37RV 
chromosomal DNA (100, 1 000, 10 000, 100 000, and 1 000 000 theoretical copies). Threshold cycle values of each 
RNA quantitation were interpolated to standard curve to obtain gene expression (number of gene copies per 
microgram of RNA). Normalization of these data was performed by using rrs gene (16 S rRNA) expression levels. 
The statistical analysis was carried out in SIGMASTAT software version 3.5, through a Two-way ANOVA and 
Turkey’s multiple-comparison, P value < 0.05 was considered significant.
Statistical analysis. Statistical testing for differential gene expression (DGE) was done using the empirical 
Bayes quasi-likelihood F-test. For all DGE analysis performed in this work, genes, functional categories and 
KEGG pathways, having a false discovery rate (FDR) <0.05 and a fold change >2 were considered significantly 
differential. PCA was performed in R on rlog49 transformed cpm of the differentially expressed genes. To produce 
the heat map52, the normalized count data of the differentially expressed genes was rescaled between −3 and 3 
and clustered based on Pearson correlation.
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The statistical analysis for qRT-PCR results was carried out in SIGMASTAT software version 3.5, through 
a Two-way ANOVA and Turkey’s multiple-comparison, to determine the significance of differences of gene 
expression between lipid and dextrose conditions. P value < 0.05 was considered significant, with one degree of 
freedom.
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